Umeclidinium and vilanterol
Generic name: Umeclidinium And Vilanterol
Brand names: Anoro Ellipta
Dosage form: inhalation powder (62.5 mcg-25 mcg/inh)
Drug class:
Bronchodilator combinations
Usage of Umeclidinium and vilanterol
Umeclidinium and vilanterol is a combination medicine used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema.
umeclidinium and vilanterol is for use only in people with COPD and should not be used to treat asthma.
Umeclidinium and vilanterol may also be used for purposes not listed in this medication guide.
Umeclidinium and vilanterol side effects
Get emergency medical help if you have signs of an allergic Reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Umeclidinium and vilanterol may cause serious side effects. Call your doctor at once if you have:
Common side effects of umeclidinium and vilanterol may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Umeclidinium and vilanterol
You should not use this medicine if you are allergic to umeclidinium or vilanterol, or if you have a severe allergy to milk proteins.
Tell your doctor if you have ever had:
Tell your doctor if you are pregnant or breastfeeding.
Umeclidinium and vilanterol is not approved for use by anyone younger than 18 years old.
Relate drugs
- Aclidinium and formoterol
- Advair
- Advair Diskus
- Advair Diskus 100/50
- Advair Diskus 250/50
- Advair Diskus 500/50
- Advair HFA
- Advair HFA 115/21
- Advair HFA 230/21
- Advair HFA 45/21
- AirDuo Digihaler with eModule
- AirDuo RespiClick
- Albuterol and ipratropium inhalation
- Anoro Ellipta
- Combivent
- Combivent Respimat
- Combivent Respimat inhalation
- Bevespi Aerosphere
- Breo Ellipta
- Breztri Aerosphere
- Budesonide and formoterol
- Budesonide and formoterol inhalation
- Budesonide, formoterol, and glycopyrrolate
- Budesonide, glycopyrrolate, and formoterol
- Duaklir Pressair
- Dulera
- DuoNeb
- Fluticasone and salmeterol
- Fluticasone and vilanterol
- Fluticasone, umeclidinium, and vilanterol
- Formoterol and glycopyrrolate
- Formoterol and mometasone
- Glycopyrrolate and formoterol
- Indacaterol and glycopyrrolate
- Ipratropium and albuterol
- Mometasone and formoterol
- Olodaterol and tiotropium
- Stiolto Respimat
- Stiolto Respimat 10 ACT
- Stiolto Respimat 28 ACT
- Stiolto Respimat 60 ACT
- Symbicort
- Symbicort Aerosphere
- Tiotropium and olodaterol
- Trelegy Ellipta
- Umeclidinium and vilanterol
- Utibron Neohaler
How to use Umeclidinium and vilanterol
Usual Adult Dose for Chronic Obstructive Pulmonary Disease -- Maintenance:
One inhalation (umeclidinium 62.5 mcg-vilanterol 25 mcg) orally once a dayMaximum dose: One inhalation every 24 hoursUse: Long term treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema
Warnings
You should not use umeclidinium and vilanterol if you are allergic to umeclidinium or vilanterol, or if you have a severe allergy to milk proteins.
Umeclidinium and vilanterol is not a rescue medicine. It will not work fast enough to treat an bronchospasm attack.
Seek medical attention if your breathing problems do not improve, or if your symptoms get worse quickly.
What other drugs will affect Umeclidinium and vilanterol
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may affect umeclidinium and vilanterol, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions